Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhoid conjugate vaccine booster study in Nepal
ISRCTN91882592Phase 4Recruiting
- Sponsor
- University of Oxford
- Start
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of TyphiBEV and typhoid conjugate vaccine in typhoid fever (2 arms), sponsored by University of Oxford. Primary endpoints: Anti-Vi IgG antibody response at Day 28 and Anti-Vi IgA antibody response at Day 28. Started Jul 2026; status: recruiting.
02
Drugs
TyphiBEVtyphoid conjugate vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on ISRCTN91882592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91882592.